Blanket Purchase Agreement W81XWH22A0005
- Not listed
- The Defense Health Agency awarded Promega Corporation an indefinite delivery vehicle in the form of a blanket purchase agreement valued at up to $11.5 million. The BPA enables the agency to place fixed price calls for DNA analysis equipment, reagents, and related products to support its biomedical research and healthcare programs. Between September 2020 and the present date, the agency has exercised this BPA to award Promega eight calls valued between $816 and $261,323.68 each. The calls require...
- <p>The Defense Health Agency established a Blanket Purchase Agreement with Promega Corporation on September 25, 2025, with a ceiling of $2.9 million and an ultimate completion date of September 24, 2030, for customized reagents and consumables.</p> <p>Place of performance is Madison, Wisconsin. A BPA call for $165,606.46 in customized reagents and consumables was awarded on January 27, 2026, with completion scheduled for February 27, 2026.</p>
- This federal Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency (DHA), a component of the U.S. Department of Defense, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and genomic testing solutions. The single-award BPA has a ceiling value of $7,433,000 and a period of performance through October 2028. Under this BPA, Qiagen will provide a range of reagents, consumables, laboratory equipment, and bioinformatics software to support DHA's...
- The Defense Health Agency established a Blanket Purchase Agreement with Edge Biosystems Inc. on September 1, 2025, with a ceiling of $2.9 million and an ultimate completion date of August 31, 2030. The BPA supports the Office of the Armed Forces Medical Examiner's mission under the Armed Forces Medical Examiner System, procuring brand-name dye terminal removal (DTR) Ultra 96-well plates and related laboratory equipment. The procurement was competitively solicited with no set-aside designation....
- This Blanket Purchase Agreement (BPA) was awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to Lucigen Corporation, a foreign-owned, for-profit manufacturer of goods. The contract has a ceiling value of $0.00 and an ultimate completion date of July 31, 2024. The BPA is for the procurement of biological materials and media. Through this contract, Lucigen Corporation has provided specialized laboratory services such as DNA isolation, whole genome sequencing, and...
- This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Defense's Medical Command (MEDCOM) to Bio-Active Company LIMITED, a for-profit limited liability company based in Thailand. The BPA provides for the delivery of maintenance, emergency, and operations services related to Illumina MiSeq genetic sequencing systems used to support infectious disease monitoring and research programs conducted by various U.S. government agencies, including the Centers for Disease Control and...
- The Defense Health Agency established a single-award Blanket Purchase Agreement with Becton, Dickinson and Company's BD Biosciences division for the procurement of laboratory reagents supporting military medical research and healthcare delivery across the Department of Defense enterprise. The BPA, awarded on September 15, 2025, carries a ceiling value of $4,000,000 and extends through September 14, 2030, with no small business set-aside applied. BD Biosciences, a global medical technology...
- Becton, Dickinson and Company, operating through its BDB Division as BD Biosciences, holds a single-award Blanket Purchase Agreement with the Office of Logistics and Acquisition Operations (a civilian federal agency) valued at $10,000,000 with an ultimate completion date of December 31, 2026. The contract was awarded on December 20, 2023, and covers the supply of biological materials, blood and blood products, chemicals, media, laboratory supplies, and animal products for operations and...
- This is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Defense's Medical Command to Biofire Defense LLC, a for-profit limited liability company based in Utah. The BPA is valued at $644,934.25 and has a period of performance from June 5, 2018 to June 11, 2023. It is a single-award contract with no set-asides used. The purpose of this BPA is to provide the Medical Command with various reagent kits and diagnostic panels for the Biofire FilmArray system platforms, including...
- This Blanket Purchase Agreement (BPA) is a single-award federal contract indefinite delivery vehicle (IDV) awarded by the Office of Logistics and Acquisition Operations, a civilian agency within the U.S. federal government. The contract, valued at a ceiling of $100,000,000, was awarded to Tecan Genomics, Inc., a Swiss-based manufacturer and distributor of automation and detection solutions for life science laboratories. The BPA is for the procurement of biological materials, specifically to...
- W81XWH22A0005Blanket Purchase Agreement
- 16Federal Contract Awards
The Defense Health Agency established a Blanket Purchase Agreement with Biodiscovery LLC on September 22, 2022, with a ceiling of $5.3 million and an ultimate completion date of September 27, 2027. Biodiscovery LLC, doing business as Daicel Arbor Biosciences, is a foreign-owned manufacturer specializing in custom molecular biology and synthetic biology solutions. The BPA procures proprietary MYBAITS custom DNA reagents, target capture and sequencing kits, and specialized genomic products for biomedical research, forensic casework analysis, and diagnostic development supporting military service members. All work is performed at Biodiscovery's facility in Ann Arbor, Michigan. The BPA is not set-aside; Biodiscovery competes openly in the federal marketplace. Recent BPA-call activity includes firm fixed-price task orders ranging from $21,485 to $609,670. Notable calls awarded in 2025 include custom MYBAITS reagents (160,000–180,000 unit quantities) valued at $275,130 on February 24, 2025; MYBAITS Mito 384 RXN reagents for $169,600 on February 13, 2025; and custom target enrichment kits for $46,320 on September 28, 2025. A $185,010 custom target enrichment kit call was awarded on January 29, 2026. Additional calls in 2024 and 2023 included MYBAITS kits, custom DNA reagents, and casework reagents. Cumulative fulfillment under this BPA has exceeded $1 million to date.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00008 | Other Administrative Action | $0 | 2/16/26 | |
| P00007 | Other Administrative Action | $0 | 2/10/26 | |
| P00006 | Other Administrative Action | $0 | 7/1/25 | |
| P00005 | Supplemental Agreement for work within scope | $0 | 4/30/25 | |
| P00004 | Supplemental Agreement for work within scope | $0 | 2/12/25 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
BPA Call W81XWH22A0005-HT942525F0096 | Biodiscovery LLC | $275.1k | 2/24/25 | 3/4/25 | 2/23/25 | |
BPA Call W81XWH22A0005-HT009024FG0210016 | Biodiscovery LLC | $22.9k | 2/6/24 | 9/30/24 | 2/5/24 | |
BPA Call W81XWH22A0005-HT942726FE010 | Biodiscovery LLC | $185.0k | 1/29/26 | 3/27/26 | 1/28/26 | |
BPA Call W81XWH22A0005-HT942525F0102 | Biodiscovery LLC | $169.6k | 2/13/25 | 2/24/25 | 2/12/25 | |
BPA Call W81XWH22A0005-HT942523F0214 | Biodiscovery LLC | $414.4k | 6/13/23 | 6/26/23 | 6/12/23 |